Skip to main content

Table 2 Thirty-six non-coding SNPs overlapping with a validated p53-RE.

From: Regression based predictor for p53 transactivation

Genes

p53 RE Location

Spacer Length

SNP ID

Allele

Wt-Binding Prediction

Minor Allele-Binding Prediction

Reference

SERTAD1

chr19: 45623874–45623893

0

rs268682

C/G

0

1

[7]

TAP1

chr6: 32929058–32929083

6

rs2228108

C/G

3

1

[10]

TP73

chr1: 3597020–3597050

11

rs12121865

A/G

2

3

[8, 10]

PLK2

chr5: 57793125–57793147

3

rs702720

A/G

1

2

[7, 9, 10]

HSP90AB1

chr6: 44322842–44322871

10

rs35074133

A/T

2

3

[10]

BDKRB2

chr14: 95740864–95740883

0

rs1800508

C/T

0

3

[9, 10]

DSCC1

chr18: 48118859–48118878

0

rs934345

C/G

2

3

[7]

TP73

chr1: 3556376–3556406

11

rs12040834

G/T

1

2

[10]

EEF1A1

chr6: 74286408–74286431

4

rs11550799

G/T

1

2

[9, 10]

EEF1A1

chr6: 74286408–74286431

4

rs11550790

G/T

1

2

[9, 10]

EEF1A1

chr6: 74286408–74286431

4

rs11556652

C/T

1

3

[9, 10]

EEF1A1

chr6: 74285585–74285606

2

rs11556679

C/G

1

1

[10]

EEF1A1

chr6: 74286408–74286431

4

rs11550844

C/T

1

1

[9, 10]

KRT8

chr12: 51585038–51585059

2

rs11554493

C/T

0

0

[10]

EEF1A1

chr6: 74285784–74285805

2

rs11556702

A/G

2

2

[10]

ADARB1

chr21: 45316682–45316701

0

rs2838769

A/G

2

2

[10]

SCGB1D2

chr11: 61765841–61765860

0

rs2232945

A/G

3

3

[7]

TP63

chr3: 190989527–190989549

3

rs9844460

C/T

4

4

[10]

EOMES

chr3: 27739623–27739643

1

rs3806624

C/T

2

2

[7]

PMS2

chr7: 6012202–6012223

2

rs2881029

A/C

1

1

[7, 10]

SIVA

chr14: 103984243–103984262

0

rs11628179

G/T

3

3

[7]

KRT8

chr12: 51585038–51585059

2

rs13098

A/T

0

0

[10]

PLK3

chr1: 45038183–45038202

0

rs17880745

A/T

2

2

[8]

PLK3

chr1: 45038183–45038208

6

rs17880745

A/T

2

2

[7, 10]

HSPA8

chr11: 122437379–122437406

8

rs11823704

A/C

0

0

[9, 10]

ARHGEF7

chr13: 110602821–110602840

0

rs1658728

G/T

3

3

[7]

RRM2B

chr8: 103318244–103318263

0

rs28999675

C/G

4

4

[7–10]

TP73

chr1: 3556358–3556385

8

rs12040834

G/T

2

2

[10]

TP73

chr1: 3597020–3597039

0

rs12121865

A/G

3

3

[7]

EEF1A1

chr6: 74285784–74285805

2

rs11550818

C/T

2

2

[10]

TRIM22

chr11: 5668357–5668376

0

rs35926783

A/G

4

4

[10]

EDN2

chr1: 41720668–41720687

0

rs11572355

A/G

3

3

[7, 8, 10]

CASP1

chr11: 104411147–104411166

0

rs3809024

A/G

3

3

[7, 10]

HSPA8

chr11: 122437379–122437406

8

rs41302367

A/G

On Spacer

On Spacer

[9, 10]

SLC38A2

chr12: 45037706–45037735

10

rs7960147

C/T

On Spacer

On Spacer

[9, 10]

MSH2

chr2: 47483388–47483420

13

rs1863332

A/C

On Spacer

On Spacer

[10]

  1. Of these, 33 SNPs overlap with dimers, out of which 10 SNPs were predicted to impact the transactivation capacity by our predictor (See Additional File 9 for more details).